Provided by Tiger Trade Technology Pte. Ltd.

TELIX PHARMACEUTICALS LTD

15.360
-0.290-1.85%
Volume:1.09M
Turnover:16.81M
Market Cap:5.20B
PE:115.29
High:15.590
Open:15.390
Low:15.260
Close:15.650
52wk High:18.320
52wk Low:8.260
Shares:338.72M
Float Shares:275.41M
Volume Ratio:0.85
T/O Rate:0.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.133
EPS(LYR):-0.029
ROE:7.36%
ROA:2.71%
PB:7.64
PE(LYR):-521.19

Loading ...

3 ASX Growth Stocks Investors Are Watching After Sharp Pullbacks

Simply Wall St.
·
Jul 15

Telix Stock And Two ASX Growth Picks Backed By Insider Ownership

Simply Wall St.
·
Jul 13

3 Fast Growing ASX Stocks With High Insider Ownership to Watch

Simply Wall St.
·
Jul 12

ASX Biggest Losers

MT Newswires Live
·
Jul 10

Fast Growing Australian Stocks Where Insider Ownership Signals Real Skin In The Game

Simply Wall St.
·
Jul 10

Champion Iron Stock And 2 Fast Growing Insider Owned Picks

Simply Wall St.
·
Jul 08

High Insider Ownership Stocks With Real Growth Potential In Australia

Simply Wall St.
·
Jul 06

Stock Track | Telix Pharmaceuticals Soars 5.15% Intraday on Positive FDA Feedback and Strong Insider Buying

Stock Track
·
Jul 06

3 ASX Growth Companies With Up To 34% Insider Ownership

Simply Wall St.
·
Jul 06

Fast Growing Australian Stocks With High Insider Ownership Worth A Closer Look

Simply Wall St.
·
Jul 05

Telix Pharmaceuticals Securing FDA Nod in Line With Expectations, Says Jefferies, Shares Down 3%

MT Newswires Live
·
Jul 03

Telix Pharmaceuticals (ASX:TLX) Clears FDA Trial Step, Does It Look Fairly Valued?

Simply Wall St.
·
Jul 03

Jefferies Sees Australia's Telix on Track for Timely U.S. Entry After Prostact FDA Clearance

Reuters
·
Jul 03

Telix Pharmaceuticals Says FDA Alignment to Advance Prostact Global Phase 3 Trial

Reuters
·
Jul 02

Australia's Telix Rises to over 9-month High as FDA Backs Prostact Study Advancement

Reuters
·
Jul 02

Telix Pharmaceuticals Gets US FDA Nod to Advance Phase 3 Prostate Cancer Trial

MT Newswires Live
·
Jul 02

Telix Pharmaceuticals - Initiation of Part 2 in U.S. Subject to FDA Ind Amendment Review

THOMSON REUTERS
·
Jul 02

Telix Pharmaceuticals Ltd-fda Alignment to Advance Prostact Global Phase 3 Trial

THOMSON REUTERS
·
Jul 02

Telix Pharmaceuticals - FDA Confirms Part 1 Safety Data Sufficient for Part 2 Progression in U.S.

THOMSON REUTERS
·
Jul 02

3 Australian Growth Stocks With High Insider Ownership Worth Watching

Simply Wall St.
·
Jul 02